Finance

Lists
Why is DERM down 2.97%?
Dive Deeper
DERM:NASDAQ
Journey Medical Corp
$3.59
-2.97%
(-0.11) 1D
Nov 17, 10:16:12 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DERM...
Open
$3.75
High
$3.81
Low
$3.59
Mkt. cap
79.81M
Avg. vol.
211.48K
Volume
6.64K
52-wk high
$9.55
52-wk low
$3.59
EPS
-$0.23
Beta
1.14
Shares outstanding
22.22M
No. of employees
58
Open
$3.75
High
$3.81
Low
$3.59
Mkt. cap
79.81M
Avg. vol.
211.48K
Volume
6.64K
52-wk high
$9.55
52-wk low
$3.59
EPS
-$0.23
Beta
1.14
Shares outstanding
22.22M
No. of employees
58
News stories
From web sources and news partners
About Journey Medical Corp
CEO-
Employees58
Founded2014
HeadquartersScottsdale, Arizona, United States
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to DERM in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DERM in the last 3 months.
Highest
Current $3.59
$13.00 (+262.12%)
Average
$12.67 (+252.92%)
Lowest
$12.00 (+234.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Buy
Maintained
$12.00
+234.3%
11/16/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$13.00
+262.1%
11/13/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$13.00
+262.1%
11/13/2026
Thomas Flaten
Lake Street
Buy
Maintained
$13.00
+262.1%
05/14/2026
Unknown Analyst
Alliance Global Partners
Buy
Reiterated
$16.00
+345.7%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
16.08M
15.96M
18.51M
18.97M
Cost of goods sold
5.44M
6.22M
6.14M
5.88M
Cost of revenue
5.44M
6.22M
6.14M
5.88M
Research and development expenses
154.00K
-
54.00K
51.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.86M
10.11M
10.89M
12.59M
Operating expense
11.08M
11.24M
11.91M
13.61M
Total operating expenses
16.52M
17.45M
18.05M
19.50M
Operating income
-443.00K
-1.49M
456.00K
-530.00K
Other non operating income
-
-
-
-
EBT including unusual items
-1.25M
-2.23M
-297.00K
-1.32M
EBT excluding unusual items
-1.25M
-2.23M
-297.00K
-1.32M
Income tax expense
-
-
15.00K
-
Effective tax rate
-
-
-5.05%
-
Other operating expenses
-
-
-
-
Net income
-1.25M
-2.23M
-312.00K
-1.32M
Net profit margin
-7.76%
-13.97%
-1.69%
-6.93%
Earnings per share
-
-
-
-
Interest and investment income
148.00K
157.00K
154.00K
140.00K
Interest expense
-933.00K
-892.00K
-906.00K
-919.00K
Net interest expenses
-785.00K
-735.00K
-752.00K
-779.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
622.00K
-366.00K
1.42M
439.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps